Search Within

Goutam Chakraborty

Formats
  1. Journal Article (23)
  2. Meeting Abstract (22)
Groups
  1. Sloan Kettering Institute Postdocs (45)
  2. Department of Medicine (34)
  3. Genitourinary Oncology Service (34)
  4. Solid Tumor Oncology Division (34)
  5. GSK Faculty (16)
  6. Human Oncology and Pathogenesis Program (9)

More Groups

People
  1. Philip Kantoff (29)
  2. Ying Mazzu (27)
  3. Yuki Yoshikawa (22)
  4. Subhiksha Nandakumar (20)
  5. Mohammad Atiq (14)
  6. Joshua Armenia (13)

More People

Years
  1. 2024 (2)
  2. 2022 (4)
  3. 2021 (5)
  4. 2020 (7)
  5. 2019 (12)
  6. 2018 (7)

More Years

Publications
  1. Cancer Research (10)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (4)
  4. Expert Opinion on Therapeutic Targets (3)
  5. Journal of Nuclear Medicine (3)
  6. Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Clinical Oncology (10)
  3. Cell Press (4)
  4. Informa Healthcare (3)
  5. Society of Nuclear Medicine (3)
  6. FEBS Press (2)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The potential of class 3 semaphorins as both targets and therapeutics in cancer
    Journal Article

    Mishra, R.; Kumar, D.; Tomar, D.; Chakraborty, G.; Kumar, S.; Kundu, G. C.
    Expert Opinion on Therapeutic Targets (2015)

    Fulltext@MSK | Save
  • Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation
    Journal Article

    Gao, H.; Chakraborty, G.; Lee-Lim, A. P.; Mavrakis, K. J.; Wendel, H. G.; Giancotti, F. G.
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Osteopontin as a therapeutic target for cancer
    Journal Article

    Bandopadhyay, M.; Bulbule, A.; Butti, R.; Chakraborty, G.; Ghorpade, P.; Ghosh, P.; Gorain, M.; Kale, S.; Kumar, D.; Kumar, S.; more...
    Expert Opinion on Therapeutic Targets (2014)

    Fulltext@MSK | Save
  • The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites
    Journal Article

    Gao, H.; Chakraborty, G.; Lee-Lim, A. P.; Mo, Q.; Decker, M.; Vonica, A.; Shen, R.; Brogi, E.; Brivanlou, A. H.; Giancotti, F. G.
    Cell (2012)

    Fulltext@MSK | Save
  • Osteopontin: A potentially important therapeutic target in cancer
    Journal Article

    Ahmed, M.; Behera, R.; Chakraborty, G.; Jain, S.; Kumar, V.; Sharma, P.; Bulbule, A.; Kale, S.; Kumar, S.; Mishra, R.; more...
    Expert Opinion on Therapeutic Targets (2011)

    Fulltext@MSK | Save